329 related articles for article (PubMed ID: 21710397)
1. In utero origins of adult insulin resistance and vascular dysfunction.
Thompson JA; Regnault TR
Semin Reprod Med; 2011 May; 29(3):211-24. PubMed ID: 21710397
[TBL] [Abstract][Full Text] [Related]
2. Fetal programming of atherosclerosis: possible role of the mitochondria.
Leduc L; Levy E; Bouity-Voubou M; Delvin E
Eur J Obstet Gynecol Reprod Biol; 2010 Apr; 149(2):127-30. PubMed ID: 20053495
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of hypertension in the cardiometabolic syndrome.
Redon J; Cifkova R; Laurent S; Nilsson P; Narkiewicz K; Erdine S; Mancia G
J Hypertens; 2009 Mar; 27(3):441-51. PubMed ID: 19262221
[TBL] [Abstract][Full Text] [Related]
4. Gestational diabetes, pregnancy hypertension, and late vascular disease.
Carpenter MW
Diabetes Care; 2007 Jul; 30 Suppl 2():S246-50. PubMed ID: 17596480
[TBL] [Abstract][Full Text] [Related]
5. Insulin resistance and endothelial dysfunction: the road map to cardiovascular diseases.
Cersosimo E; DeFronzo RA
Diabetes Metab Res Rev; 2006; 22(6):423-36. PubMed ID: 16506274
[TBL] [Abstract][Full Text] [Related]
6. The role of obesity and its bioclinical correlates in the progression of chronic kidney disease.
Chalmers L; Kaskel FJ; Bamgbola O
Adv Chronic Kidney Dis; 2006 Oct; 13(4):352-64. PubMed ID: 17045221
[TBL] [Abstract][Full Text] [Related]
7. The role of insulin resistance in the pathogenesis of atherosclerotic cardiovascular disease: an updated review.
Reddy KJ; Singh M; Bangit JR; Batsell RR
J Cardiovasc Med (Hagerstown); 2010 Sep; 11(9):633-47. PubMed ID: 20164784
[TBL] [Abstract][Full Text] [Related]
8. [In utero fetal programming and its impact on health in adulthood].
Ramírez-Vélez R
Endocrinol Nutr; 2012; 59(6):383-93. PubMed ID: 22483564
[TBL] [Abstract][Full Text] [Related]
9. Tracing the origins of "fetal origins" of adult diseases: programming by oxidative stress?
Luo ZC; Fraser WD; Julien P; Deal CL; Audibert F; Smith GN; Xiong X; Walker M
Med Hypotheses; 2006; 66(1):38-44. PubMed ID: 16198060
[TBL] [Abstract][Full Text] [Related]
10. Effects of insulin resistance on endothelial progenitor cells and vascular repair.
Cubbon RM; Kahn MB; Wheatcroft SB
Clin Sci (Lond); 2009 Aug; 117(5):173-90. PubMed ID: 19630751
[TBL] [Abstract][Full Text] [Related]
11. Insulin resistance in obesity as the underlying cause for the metabolic syndrome.
Gallagher EJ; Leroith D; Karnieli E
Mt Sinai J Med; 2010; 77(5):511-23. PubMed ID: 20960553
[TBL] [Abstract][Full Text] [Related]
12. Exposure in utero to maternal diabetes leads to glucose intolerance and high blood pressure with no major effects on lipid metabolism.
Blondeau B; Joly B; Perret C; Prince S; Bruneval P; Lelièvre-Pégorier M; Fassot C; Duong Van Huyen JP
Diabetes Metab; 2011 Jun; 37(3):245-51. PubMed ID: 21257329
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of postprandial hyperglycemia by acarbose is a promising therapeutic strategy for the treatment of patients with the metabolic syndrome.
Yamagishi S; Nakamura K; Takeuchi M
Med Hypotheses; 2005; 65(1):152-4. PubMed ID: 15893133
[TBL] [Abstract][Full Text] [Related]
14. Hypertension and dyslipidaemia in obesity and insulin resistance: pathophysiology, impact on atherosclerotic disease and pharmacotherapy.
Chapman MJ; Sposito AC
Pharmacol Ther; 2008 Mar; 117(3):354-73. PubMed ID: 18215759
[TBL] [Abstract][Full Text] [Related]
15. Obesity, blood vessels and metabolic syndrome.
Tesauro M; Cardillo C
Acta Physiol (Oxf); 2011 Sep; 203(1):279-86. PubMed ID: 21439028
[TBL] [Abstract][Full Text] [Related]
16. Endothelial dysfunction in obesity: etiological role in atherosclerosis.
Meyers MR; Gokce N
Curr Opin Endocrinol Diabetes Obes; 2007 Oct; 14(5):365-9. PubMed ID: 17940464
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms underlying developmental programming of elevated blood pressure and vascular dysfunction: evidence from human studies and experimental animal models.
Nuyt AM
Clin Sci (Lond); 2008 Jan; 114(1):1-17. PubMed ID: 18047465
[TBL] [Abstract][Full Text] [Related]
18. The thrifty 'catch-up fat' phenotype: its impact on insulin sensitivity during growth trajectories to obesity and metabolic syndrome.
Dulloo AG; Jacquet J; Seydoux J; Montani JP
Int J Obes (Lond); 2006 Dec; 30 Suppl 4():S23-35. PubMed ID: 17133232
[TBL] [Abstract][Full Text] [Related]
19. New approach in the treatment of T2DM and metabolic syndrome (focus on a novel insulin sensitizer).
Tjokroprawiro A
Acta Med Indones; 2006; 38(3):160-6. PubMed ID: 17119268
[TBL] [Abstract][Full Text] [Related]
20. Insulin resistance, metabolic syndrome and vascular diseases: update on mechanistic linkages.
Lteif A; Mather K
Can J Cardiol; 2004 Aug; 20 Suppl B():66B-76B. PubMed ID: 15309208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
